Kanagawa, Japan

Sayaka Mori

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Farnex Incorporated. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sayaka Mori. Retrieved from https://idiyas.com/inventor/sayaka-mori-gx1onoer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sayaka Mori - Innovator in External Preparations

Introduction

Sayaka Mori is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of external preparations that enhance drug permeability.

Latest Patents

Mori holds a patent for an external preparation comprising a non-lamellar liquid crystal-forming lipid. This innovative formulation is designed to be well retained on the surface of living bodies, thereby increasing the effectiveness of drug delivery.

Career Highlights

Sayaka Mori is associated with Farnex Incorporated, where she continues to advance her research and development efforts. Her work focuses on creating formulations that improve the therapeutic efficacy of drugs.

Collaborations

Mori collaborates with notable colleagues, including Kenji Sugibayashi and Hiroaki Todo, who contribute to her research initiatives and projects.

Conclusion

Sayaka Mori's innovative work in external preparations showcases her commitment to enhancing drug delivery systems. Her contributions are paving the way for advancements in pharmaceutical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…